The NDP has a new leader. What does Avi Lewis’s arrival mean for the party?
The ndp leadership change impact is significant with Avi Lewis taking the helm. This shift could influence the party's strategies and public perception. Understanding these changes is key for political observers.
13 Cannabis Articles Clinical Relevance Review — March 29, 2026
This review covers 13 cannabis articles clinical relevance scores as of March 29, 2026. The articles provide insights into evolving cannabis research and policy. Clinicians will find valuable updates on cannabis clinical evidence.
Medicare CBD Regulatory Cliff: Why FDA Enforcement Must Precede Federal Reimbursement
Medicare CBD reimbursement risks highlight the need for FDA enforcement before federal coverage. Without FDA standards, clinicians face challenges prescribing safe, effective CBD. This article explains why regulatory clarity is essential for Medicare…
Rescheduling Cannabis Under the Controlled Substances Act | Regulatory Review
Rescheduling cannabis regulatory impact under the Controlled Substances Act could transform research and clinical practice. Lower scheduling may enable more rigorous trials and standardized product development. This shift is crucial for advancing…
Innovative Industrial Properties: Undervalued Amid Cannabis Rescheduling Milestone
The cannabis rescheduling milestone marks a pivotal change in federal law, impacting medical cannabis research and clinical practice. This shift to Schedule III could accelerate pharmaceutical development and alter regulatory frameworks. Understanding…
Pot Inc. Awaits DOJ Marijuana Reclassification Decision Amid Delays
The DOJ marijuana reclassification delay continues to affect medical cannabis research and clinical practice. This postponement hinders progress toward Schedule III status, which could improve research opportunities. Understanding this delay is crucial…
Federal CBD Health Insurance Plan Allows THC Above Hemp Limit
Federal CBD insurance coverage now permits products with up to 3mg THC per dose, marking a significant policy shift. This change impacts dosing and safety considerations for clinicians. Understanding this federal cbd insurance coverage is crucial for…
Lowcountry Hemp Sellers Challenge DEA Enforcement Actions
Hemp-derived THC enforcement by the DEA has led to raids on Lowcountry hemp retailers, prompting legal challenges. These actions highlight federal uncertainty around hemp products. The lawsuit aims to clarify enforcement and protect hemp businesses.
Congressional Researchers Provide Update on Marijuana Rescheduling and Hemp Policy
Marijuana rescheduling federal research is under active congressional review, affecting clinical practice and research access. Current federal Schedule I status limits federally funded cannabis studies. Changes in rescheduling could enhance…
Feds Maintain Marijuana Testing Despite Cannabis Reclassification
Federal workplace drug testing policies continue to screen for marijuana metabolites despite cannabis reclassification. This creates challenges for patients using cannabis medicinally in safety-sensitive jobs. Clinicians should counsel patients on the…
